Monoclonal Antibody Therapy
- All
- News
- Videos
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
-
"Symptoms Gone In A Day": Doctor On Antibody Cocktail To 40 In Hyderabad
As many as 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad's Asian Institute of Gastroenterology. "In 24 hours, they recovered from clinical symptoms like fever, malaise etc," said top doctor.
-
After New Antibody Therapy, 2 Covid Patients Discharged From Delhi Hospital In 12 Hours
Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two Covid patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged with 12 hours.
-
Monoclonal Antibody Therapy Improved Parameters In 2 Covid Patients: Delhi Hospital
Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday.
-
Two Elderly Covid Patients, Who Got Antibody Therapy On June 1, Test -ve
Two Covid-positive senior citizens with heart complications, who were administered the monoclonal antibody therapy at a leading private facility in Delhi a week ago, have "tested negative" for the coronavirus infection.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Antibody Cocktail Therapy Begins At Delhi's Sir Ganga Ram Hospital
Delhi's premier Ganga Ram Hospital has started administration of Monoclonal Antibody Cocktail from June 1. The new therapy -- which carries a lot of hope for Covid patients -- is a combination of Casirivimab and Imdevimab.
-
Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients
Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
-
"Symptoms Gone In A Day": Doctor On Antibody Cocktail To 40 In Hyderabad
As many as 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad's Asian Institute of Gastroenterology. "In 24 hours, they recovered from clinical symptoms like fever, malaise etc," said top doctor.
-
After New Antibody Therapy, 2 Covid Patients Discharged From Delhi Hospital In 12 Hours
Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two Covid patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged with 12 hours.
-
Monoclonal Antibody Therapy Improved Parameters In 2 Covid Patients: Delhi Hospital
Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday.
-
Two Elderly Covid Patients, Who Got Antibody Therapy On June 1, Test -ve
Two Covid-positive senior citizens with heart complications, who were administered the monoclonal antibody therapy at a leading private facility in Delhi a week ago, have "tested negative" for the coronavirus infection.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Antibody Cocktail Therapy Begins At Delhi's Sir Ganga Ram Hospital
Delhi's premier Ganga Ram Hospital has started administration of Monoclonal Antibody Cocktail from June 1. The new therapy -- which carries a lot of hope for Covid patients -- is a combination of Casirivimab and Imdevimab.
-
Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients
Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
